AP-PA field orientation followed by IMRT reduces lung exposure in comparison to conventional 3D conformal and sole IMRT in centrally located lung tumors

Radiation Oncology

Volumn 7, Issue 1, 2012, Pages

  Soyfer, Viacheslav ^a   Meir, Yaron ^a   Corn, Benjamin W ^a   Schifter, Dan ^a   Gez, Eliahu ^a   Tempelhoff, Haim ^a   Shtraus, Natan ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

3D; AP PA; IMRT; Lung cancer; Radiation

Indexed keywords

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CLINICAL ARTICLE; ESOPHAGUS; FEMALE; HUMAN; HUMAN TISSUE; INTENSITY MODULATED RADIATION THERAPY; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; LUNG SMALL CELL CANCER; MALE; RADIATION EXPOSURE; SPINAL CORD; COMPARATIVE STUDY; COMPUTER ASSISTED RADIOTHERAPY; CONSERVATIVE TREATMENT; LUNG TUMOR; MIDDLE AGED; ORIENTATION; PROGNOSIS; RADIATION DOSE; RADIATION INJURY; THREE DIMENSIONAL IMAGING;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; ESOPHAGUS; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; LUNG NEOPLASMS; MALE; MIDDLE AGED; ORGAN SPARING TREATMENTS; ORIENTATION; PROGNOSIS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; SMALL CELL LUNG CARCINOMA; SPINAL CORD;

EID: 84856920255     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-7-23     Document Type: Article

References (25)

1. http://seer.cancer.gov/csr/1975_merged/sect_15lung_bronchus.pdf11
2. Bradley J, Graham MV, Winter K, Purdy JA, Komaki R, Roa WH, Ryu JK, Emami B. Toxicity and outcome results of RTOG 9311: a phase 1-2 dose escalation study using three- dimensional conformal radiotherapy (> 59 Gy) and concurrent chemotherapy in non-small-cell lung cancer. Ann Thorac Surg 2004, 78:1200-5. 10.1016/j.athoracsur.2004.04.085, 15464470.
3. Kong F, Gaspar LE, Komaki R, Sun A, Bonner JA, Choy H, Wang L, Morris D, Sandler HM, Movsas B. Patterns of practice in radiation dose prescription and treatment planning for patients with lung cancer among members of American Society of Therapeutic Radiology and Oncology (abstract). Int J Radiat Oncol Biol Phys 2007, 69(3 Suppl 1):483.
4. Wang L, Correa CR, Zhao L, Hayman J, Kalemkerian GP, Lyoms S, Cease K, Brenner D, Kong FM. The effect of radiation dose and chemotherapy on overall survival in 237 patients with Stage 3 non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2007, 68:103-10. 10.1016/j.ijrobp.2006.11.051, 17363189.
5. Payne D, Warde P. Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol 1992, 10(6):890-5.
6. Zhu H, Zhou ZM, Ou GF, Liang J, Zhang XR, Zhang HX, Chen DF, Xiao ZFWang LH. Thoracic Radiation Therapy (TRT) Improved Overall Survival for Patients with Extensive Stage Small Cell Lung Cancer. Int J Radiat Biol Phys 2010, 78(3):522-523.
7. http://www.nccn.org/professionals/physician_gls/pdf/sclc.pdf
8. Graham MV, Pudry JA, Emami B, Harms W, Bosch W, Lockett MA, Perez CA. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Ocnol Biol Phys 1999, 45(2):323-9.
9. Singh A, Locket MA, Bradly JD. Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2003, 55(2):337-41. 10.1016/S0360-3016(02)03937-8, 12527046.
10. Lievens Y, Nulens A, Gaber MA, Defraene G, Wever WD, Stroobants S, Heuvel FD. Intensity Modualated Radiotherapy for locally advanced Non-Small-Cell Lang Cancer: A dose-escalation planning study. Int J Radiat Oncol Biol Phys 2011, 80(1):306-13. 10.1016/j.ijrobp.2010.06.025, 20888706.
11. Kitpatrick JP, Van Der Kogel AJ, Schultheiss TE. Radiation dose-volume effects in spinal cord. Int J Radiat Oncol Biol Phys 2010, 76(3 Suppl):S42-9.
12. Liu H, Wang X, Dong L, Wu Q, Stevens CW, Guerrero TM, Komaki R, Cox JD, Mohan R. Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2004, 58:1268-1279. 10.1016/j.ijrobp.2003.09.085, 15001272.
13. Murshed S, Liu H, Liao Z, Barker JL, Wang X, Tucker SL, Chandra A, Stevens C, Chang JY, Jeter M, Cox JD, Komaki R, Mohan R. Dose and volume reduction for normal lung using intensity-modulating radiotherapy for advanced stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2004, 58(4):1258-1267. 10.1016/j.ijrobp.2003.09.086, 15001271.
14. Allen AM, Czerminska M, Janne PA, et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int J Radiat Oncol Biol Phys 2006, 65:640-645. 10.1016/j.ijrobp.2006.03.012, 16751058.
15. Mayo CS, Urie MM, Fitzgerald TJ, Ding L, Lo YC, Bogdanov M. Hybrid IMRT for treatment of cancer of the lung and esophagus. Int J Radiat Oncol Biol Phys 2008, 71(5):1408-1418. 10.1016/j.ijrobp.2007.12.008, 18262730.
16. Chan OS, Lee MC, Hung AW, Chang AT, Yeung RM, Lee AW. The superiority of hybrid- volumetric arc therapy (VMAT) technique over double arc VMAT and 3D- conformal technique in the treatment of locally advanced non-small cell lung cancer- A planning study. Radiother Oncol 2011, 101(2):298-302. Epub 2011 Sep 8, 10.1016/j.radonc.2011.08.015, 21907438.
17. Jatinder R, Palta T. Rockwell Mackie: Intensity- Modulated radiation Therapy. The State of the Art 2003, 67.
18. International Commission on Radiation Units and Measurements Prescribing, recording and reporting photon beam therapy ICRU Report 62. 2010, Bethesda, MD: international Commission on Radiation Units and Measurements, International Commission on Radiation Units and Measurements.
19. Onimaru R, Shirato H, Fujino M, et al. The effect of tumor location and respiratory function on tumor movement estimated by real-time tracking radiotherapy (RTRT) system. Int J Radiat Oncol Biol Phys 2005, 63(1):164-169. 10.1016/j.ijrobp.2005.01.025, 16111585.
20. Plathow C, Fink C, Ley S, et al. Measurement of tumor diameter-dependent mobility of lung tumors by dynamic MRI. Radiother Oncol 2004, 73(3):349-354. 10.1016/j.radonc.2004.07.017, 15588881.
21. Perez C, Brady WL, Halperin CE, Schmidt-Ullrich RK. Principles and Practice of Radiation Oncology 2004, 1218. fourth.
22. Halperin CE, Perez C, Brady. Principles and Practice of Radiation Oncology 2008, 1103. fifth.
23. Claude L, Perol D, Ginestet C, et al. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: Clinical and dosimetric factors analysis. Radiother Oncol 2004, 71:175-181. 10.1016/j.radonc.2004.02.005, 15110451.
24. Shueng PW, Lin SC, Chang HT, Chong NS, Chen YJ, Wang LY, Hsieh YP, Hsieh CH. Toxicity risk on non-target organs at risk receiving low-dose radiation: case report. Radiat Oncol 2009, 4:71. 10.1186/1748-717X-4-71, 2806297, 20043839.
25. Shi A, Zhu G, Wu H, Yu R, Li F, Xu B. Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-smal cell lung cancer treated with concurrent chemotherapy and intensity- modulated radiotherapy. Radiat Oncol 2010, 5:35. 10.1186/1748-717X-5-35, 2883984, 20462424.